Universal Health Realty's 38-Year Dividend Streak Faces Balance Sheet Scrutiny
For income investors, few records command as much respect as a decades-long streak of dividend growth. Universal Health Realty Income Trust (NYSE:UHT), a healthcare-focused real estate investment trust, has delivered precisely that, raising its payout every single year since the late 1980s. At a recent share price of $43.64, its dividend yields approximately 6.8%, a tempting premium over the 10-year Treasury yield. Yet, beneath the surface of this impressive track record, financial metrics are flashing cautionary signals that suggest the trust's celebrated income stream may be on less solid ground than its history implies.
The dividend story is undeniably compelling. From an annualized rate of about $1.80 in 1999, UHT has steadily increased its distribution to a current run rate of $2.96 per share. Its most recent hike in December 2025, though modest, extended the unbroken streak. For REITs, the key measure of payout health is Funds From Operations (FFO). Here, the picture appears manageable, with a projected 2025 FFO payout ratio around 86%. Furthermore, CEO Alan B. Miller's purchase of over 12,000 shares in October 2025 signaled insider confidence amid depressed share prices.
However, a look at the balance sheet and GAAP earnings tells a different story. Shareholders' equity has declined consecutively throughout 2025, dropping from $172.2 million to $152.4 million, as cumulative dividends outpace retained earnings. Net income for 2025 fell to $17.6 million, far below the $41.0 million paid out in dividends—a gap that results in a stark GAAP payout ratio of over 236%. While this discrepancy is partly due to non-cash depreciation charges, it highlights a steady erosion of book value.
Operational headwinds are adding pressure. A key medical office property in Amarillo, Texas, sits vacant after tenants departed, contributing to a 7.2% year-over-year decline in Q4 net income. More structurally, interest expense has more than doubled since 2022, reaching $21.9 million in 2025, a significant drag that persists despite a stabilized interest rate environment.
The trust's near-term hopes are pinned on new developments, notably the Palm Beach Gardens Medical Plaza I, which broke ground in February 2026. With a major subsidiary of its parent company, Universal Health Services, pre-leasing 75% of the space, the project promises a new revenue stream by late 2026. Its success is critical.
Analyst & Investor Commentary:
"The FFO coverage remains adequate, and the development pipeline provides a clear catalyst. This is a story of a proven operator navigating a tough rate environment, not a dividend cut in waiting," says Michael R. Carter, a portfolio manager at Horizon Income Advisors.
"Management is betting the farm on new projects while the core equity dwindles. That 236% payout ratio isn't just an accounting quirk—it's a warning sign that the streak is being financed by eating the company's seed corn," argues Lisa Torrence, an independent financial blogger known for her bearish takes on REITs.
"For a long-term holder like me, the consistent cash flow is what matters. The Amarillo vacancy is a temporary setback, and the insider buying tells me leadership believes in the turnaround," shares David Chen, a retired dentist and UHT shareholder since 2010.
Ultimately, Universal Health Realty's 38-year dividend legacy is not in immediate peril, thanks to its FFO coverage. But the balance sheet reveals a shrinking safety net. The trust's ability to re-lease its vacant properties and successfully integrate new developments will determine whether this venerable income streak can extend its run into the next decade.